Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

SLS Stock Forecast, Price Targets, Chart, Dividends & Analysis

SELLAS Life Sciences Group Inc. logo

SELLAS Life Sciences Group Inc.

Sector: Healthcare   

Industry: Biotechnology

0.89
 
USD
  
-0.01
  
(-1.11%)
Previous close: 0.898  Open: 0.91  Bid: 0.8901  Ask: 0.95
52 week range    
0.50   
   1.72
Mkt Cap: 62 M  Avg Vol (90 Days): 973,486
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

42
MarketXLS Rank
60
Value
30
Technical
36
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

SLS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends675000.014 M9 M17 M21 M
AcquiredInProcessRnD-19 M
Amortization of intangibles-440000.02 M2 M2 M2 M
Basic EPS from continuing operations-1.34-1.34
Basic EPS total-1.34-2.13-1.34
Basic weighted shares outstanding2 M5175.0199176.046807.0261542.03 M8 M15 M19 M28 M
Cost of sales-1 M-5 M200000.0-100000.0
Depreciation-362000.0-107000.0-142000.0
Depreciation unreconciled2 M
DepreciationAndAmortization-362000.0-107000.0-142000.02 M
Diluted EPS total-15.5-12300.0-118.0-522.0-157.5-10.92-2.11-1.34-2.13-1.34
Diluted normalized net income/share-10.92-2.11-1.34-1.34
Diluted weighted shares outstanding2 M3167.094076.045505.0175511.03 M8 M15 M19 M28 M
DilutedDiscontinuousOperations-4800.0-62.5
GainOnSaleOfPPE-17 M
GainOnSaleOfSecurity-5 M
GeneralAndAdministrativeExpense-200000.0-200000.0-300000.0-400000.010 M11 M-500000.014 M
Gross operating profit8 M5 M2 M7 M900000.0
Income before tax-28 M-39 M-11 M-24 M-29 M-39 M-17 M-21 M-41 M-37 M
Income restructuring and M&A-28 M-2 M
Income taxes365000.01000.0253000.0-1 M-81000.0-17000.0-237000.0
Interest income15 M402000.019 M296000.0
InterestExpenseNonOperating-118000.0-26000.0-6000.0-525000.0
MiscOtherSpecialCharges170000.0509000.0-526000.06 M550000.0182000.04 M36000.04000.0
Net income from total operations-28 M-64 M-24 M-24 M-28 M-39 M-17 M-21 M-41 M-37 M
NetIncomeCommonStockholders-28 M-39 M-18 M-24 M-41 M-47 M-17 M-21 M-41 M-37 M
NetIncomeContinuousOperations-28 M-64 M-24 M-24 M-28 M-39 M-17 M-21 M-41 M-37 M
NetIncomeDiscontinuousOperations-8 M-25 M-12 M
NetNonOperatingInterestIncomeExpense15 M402000.019 M118000.026000.06000.0296000.0525000.0
NetOperatingInterestIncomeExpense-1 M-462000.0-266000.0317000.0
NonRecurringOperationExpense5 M3 M-1 M
Normalized income-15 M
Operating income-44 M-34 M-16 M-23 M-25 M-17 M-17 M-25 M-42 M-38 M
Operating income before depreciation (EBITDA)-28 M-39 M-11 M-23 M-29 M-39 M-17 M-20 M-41 M-37 M
OperatingExpense-44 M-34 M32 M23 M25 M17 M19 M27 M43 M38 M
Other income net-170000.0-509000.0526000.0-13 M3 M2 M-182000.01 M-36000.0-4000.0
OtherGandA-200000.0-200000.0-300000.0-400000.010 M11 M-500000.014 M
OtherImpairmentOfCapitalAssets-8 M10 M3 M6 M
OtherOperatingExpenses16 M11 M12 M-28000.04 M586000.095000.0300000.0500000.0
OtherunderPreferredStockDividend675000.014 M9 M17 M21 M
PreferredStockDividends675000.014 M9 M17 M21 M
RentAndLandingFees-200000.0-200000.0-300000.0
Research & development expense28 M24 M11 M6 M9 M7 M9 M16 M30 M24 M
ResearchExpense28 M24 M11 M6 M9 M7 M9 M16 M30 M24 M
RestructringAndMnAIncome-28 M-2 M
Revenue per share-440000.02 M2 M3 M2 M
SalariesAndWages-5 M-354000.0-3 M-395000.0-573000.0-578000.0-2 M
Selling Gen & administrative expense5 M15 M13 M10 M10 M11 M13 M14 M
SellingAndMarketingExpense5 M15 M13 M10 M10 M13 M
SellingExpense5 M15 M13 M10 M10 M13 M
Special income/charges-5 M28 M2 M-19 M
Total Income available for interest expense (EBIT)-28 M-39 M-11 M-24 M-29 M-39 M-17 M-20 M-41 M-38 M
Total common shares outstanding4456.06058.025885.04381.0463529.07 M15 M16 M28 M56 M
Total net income-28 M-64 M-24 M-24 M-28 M-39 M-17 M-21 M-41 M-37 M
Total ordinary shares70 M70 M70 M70 M70 M70 M70 M70 M70 M70 M
Total revenues9 M2 M8 M1000000.0
TotalExpenses-44 M-34 M32 M18 M25 M17 M19 M27 M43 M38 M
TotalRevenue9 M2 M8 M1000000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University